Somatostatin receptors ligands in radionuclide diagnosis and therapy in oncology;Ligandy receptorów somatostatynowych w diagnostyce i terapii radioizotopowej w onkologii

Nowotwory

Volumn 52, Issue 3, 2002, Pages 227-234

  Cholewiński, Witold ^a   Tarkowska, Anna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Octreotide; Receptor scintigraphy; Somatostatin receptors

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; INDIUM; OCTREOTIDE; PENTETIC ACID; PENTETREOTIDE; RADIOACTIVE IODINE; RADIOISOTOPE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 5; UNCLASSIFIED DRUG;

BINDING AFFINITY; CANCER RADIOTHERAPY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG RECEPTOR BINDING; GENE EXPRESSION; HUMAN; IMAGE ANALYSIS; NEUROENDOCRINE TUMOR; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCINTISCANNING;

EID: 0036037666     PISSN: 0029540X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
2. The role of somatostatin and its analogs in the diagnosis and treatment of tumors
3. Somatostatin receptor scintigraphy with 111In-DTPA-D-Phel]- and [123I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients
4. Somatostatin receptor-mediated imaging and therapy: Basic science, current knowledge, limitation and future perspectives
5. Molecular pharmacology of somatostatin receptor subtypes
6. Classification and nomenclature of somatostatin receptors
7. Treatment of neuroendocrine GEP tumours with somatostatin analogues: A review
8. Expression of five different somatostatin receptor subtypes in endocrine cells of the pancreas
9. Traitement des tumeurs endocrines par les analogues de la somatostatine
10. Neuropeptide receptors in health and disease: The molecular basis for in vivo imaging
11. Somatostatin and its receptor family
12. Somatostatin receptors in human prostate and prostate cancer
13. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: In vitro identification
14. Receptor nuclear medicine: Vasointestinal peptide and somatostatin receptor scintigraphy for diagnosis and treatment of tumor patients
15. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
16. Somatostatin receptor subtype gene expression in pituitary adenomas
17. Use of octreotide acetate for control of symptoms in patients with islet cell tumors
18. Receptor scintigraphy with a radioiodinated somatostatin analogue: Radiolabelling, purification, biological activity and in vivo application in animals
19. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phel]-octreotide in man: Metabolism, dosimetry and comparison with [123-Tyr-3q-]-octreotide
20. Affinity profiles for human somatostatin receptor subtypes sst1-sst5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use
21. Somatostatin receptor subtypes st1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-panereatic and mammary tumors: Comparison of mRNA analysis with receptor autoradiography
22. Somatostatin receptor sub-types in human thymoma and inhibition of cell proliferation by octreoticle in vitro
23. Indium-111-diethylenetriamine pentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes
24. Indium-111-DOTA-lanreotide: Biodistribution, safety and radiation absorbed dose in tumor patients
25. 99mTc-EDDA/HYNICTOC: A new 99mTc-labelled radiopharmaccutical for imaging somatostatin receptor-positive turmours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives
26. Detection of somatostatin receptor-positive tumours using the new 99mTc-tricinc-HYNIC-D-Phel-Tyr3-octreotide: First results in patients and comparison with 111In-DTPA-D-Phe1-octreotide
27. 111In-pentetreotide scintigraphy in the detection of insulinomas: Importance of SPECT imaging
28. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas
29. Somatostatin receptor scintigraphy in pituitary adenomas: A somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivo
30. Prognostic value of receptors for insulin-like growth factor 1, somatostatin and epidermal growth factor in human breast cancer
31. Somatostatin receptor imaging in intracranial tumours
32. Somatostatin receptor scintigraphy in the staging of lymphomas
33. Grave's ophtalmopathy: Current concept regarding pathogenesis and management
34. Somatostatin and the immune and haematopoietic system: A review
35. Retrobulbal histology and immunohistochemistry in endocrine ophtalmopathy
36. Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease
37. Auger-electron spectres of radionuclides for therapy and diagnosis
38. In situ radiotherapy with 111In-pentetrcotide. State of the art and perpectives
39. Yurium-90 DOTATOC: First clinical results
40. Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue
41. [213Bi-DOTA0,Tyr3]-octreotide in peptide receptor radionuclide therapy
42. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors
43. Gene therapy for pancreatic carcinoma: Local and distant antitumor effects after somatostatin receptor sst2 gene transfer